Hematological indices reference intervals for a healthy Arab population in Qatar

Abstract

Hematologic reference intervals vary with gender, age, ethnicity, and geographic area. Therefore, local or national laboratory reference ranges are essential to enhance the accuracy when diagnosing health conditions. Still, no comprehensive list of reference ranges tailored to the Arab population living in Qatar. Accordingly, this study aims at establishing a hematology reference guide for Arabs in Qatar.This is a retrospective study where 750 healthy volunteers (18–69 years) from 2015 to 2019 were included, analyzed by an automated hematology analyzer. Arab adults were divided into African (Egypt, Libya, Tunisia, Morocco) and Asian (Syria, Lebanon, Jordon, Palestine, Qatar). The Cell-Dyn and Sysmex were used for measuring hematological parameters.The mean +/- 2SD were established for all the study groups. Arab males had significantly higher Hb, Hct, red cell distribution width, absolute neutrophil count, lymphocytes, and monocyte counts than females. Asian-Arab males had significantly higher Hb concentration and higher WBC, lymphocytes, and eosinophils than African Arabs. Asian-Arab young (>18: < 40 years) males had significantly higher Hb and lymphocytes and lower monocytes than older males (>40 years). African-Arab young males had significantly higher lymphocytes and lower monocytes than older males. Asian-Arab young females had higher WBC and absolute neutrophil count than older Asian Arabs.The findings of this study will help in establishing specific reference intervals in the Arab world. The differences in hematology reference intervals considering age, gender, and geographical location highlight the importance of establishing blood reference intervals in each country considering the ethnic diversity of each country.

A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation Dilemma

“…Eltrombopag is associated with an infrequent increase in thromboembolic events [10,11]. In the EXTEND trial, 11 out of 299 patients (4%) developed thromboembolic events [4].…”

Omicron-Induced Immune Thrombocytopenia: A Case Report

“…Immune thrombocytopenic purpura (ITP) is a hematologic disorder in which antibodies coating platelets cause platelet destruction in the spleen, resulting in a low platelet count and an increased tendency to bleed [ 7 ]. Cases of ITP have been recorded in coronavirus disease 2019 (COVID-19) vaccination recipients with a platelet count of lower than 100,000, including new-onset ITP and worsening of pre-existing ITP [ 8 ].…”